Friday Dec 13, 2024
Friday Dec 13, 2024
Thursday, 6 August 2015 00:00 - - {{hitsCtrl.values.hits}}
Chariot Restaurants General Manager Mohan H. Bibile, LAHRC Director/General Manager Upul Gamage, Human Resources Manager Senani De Silva and Credence Genomics CEO/Director Dr. Vaz Gnanam 
LAHRC Director/General Manager Upul Gamage, Credence Genomics CEO/Director Dr. Vaz Gnanam
Credence Sri Lanka’s foremost and pioneering venture in genomic medicine has been identified as a leader in clinical genomics and the only commercial provider of next generation sequencing. Credence now offers its cutting edge services through partner hospitals, labs and pharmacies island-wide. The organisation now offers corporate testing to the all the staff and managers of LAHRC management services.
LAHRC is a leader in the food retail and services industry with popular names such as St. Lachlan Hotel, Reefs Edge hotel, Chariot Restaurants, The Regent Country Club and others. LAHRC believes that offering good quality healthcare advice and screening services are important to their staff. Joining hands with Credence all of the management of LAHRC will be offered pre test counselling services to evaluate their risk of cancer or heart disease.
The tests offered by Credence are 99.7% specific and cover the major cancers, which are breast cancer and colorectal cancer. Furthermore heart disease accounts for almost 40% of all non-communicable diseases in Sri Lanka and the Credence comprehensive heart package evaluates the risk that individuals are pre disposed to genetically, thus allowing them to modify their lifestyles for a better quality of life, especially considering today’s hectic corporate environments.
LAHRC sees a lot of value in improving the quality of health of their individual employees.
“We thank the management of LAHRC and their related companies for acknowledging the benefits of using Credence for improving the quality of their staff. We believe the value that we bring will reflect not only on their staff but will benefit their families as well,” said Credence Genomics CEO/Director Dr. Vaz Gnanam.
